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Abstract: Several investigations suggested abnormalities in circadian rhythms are related to the pathophysiology of   
psychiatric disorders, including drug addiction. Recently, orphan nuclear receptor rev-erb alpha and glycogen synthase 
kinase-3  (GSK-3) were shown to be important circadian components. In addition, the orphan nuclear receptor rev-erb 
alpha is a key negative feedback
  regulator of the circadian clock. These evidences indicate that rev-erb alpha gene 
(NR1D1) is a good candidate gene for the pathogenesis of methamphetamine dependence. To evaluate the association  
between NR1D1 and methamphetamine dependence, we conducted a case-control study of Japanese samples (215 meth-
amphetamine dependence and 232 controls) with three tagging SNPs selected by HapMap database. Written informed 
consent was obtained from each subject. This study was approved by the ethics committees at Fujita Health University, 
Nagoya University Graduate School of Medicine and each participating member of the Institute of the Japanese Genetics 
Initiative for Drug Abuse (JGIDA). We did not detect an association between NR1D1 and Japanese methamphetamine  
dependence patients in allele/genotype-wise analysis, or the haplotype analysis. Our findings suggest that NR1D1 does not 
play a major role in the pathophysiology of methamphetamine dependence in the Japanese population. 
Keywords: Orphan nuclear receptor Rev-erb alpha gene (NR1D1), methamphetamine dependence, tagging SNPs, linkage   
disequilibrium. 
1. INTRODUCTION 
  Several investigation suggest that abnormalities in   
circadian rhythms may be involved in the pathophysiology 
of psychiatric disorders, including drug addiction [1-3].   
The evidence for this relation is discussed in more detail   
in our previous papers and a review by Barnard and Nolan 
[4-7]. 
  Recently, Mohawk and colleagues reported that mice 
which were arrhythmic due to a lack of circadian clock genes 
showed circadian locomotor rhythms when treated with 
methamphetamine [8]. If patients with drug addiction disor-
ders had disrupted circadian rhythms, it is possible that tak-
ing methamphetamine helps to restore circadian rhythms of 
taking into methamphetamine to keep to circadian rhythm. 
Several animal studies have shown that methamphetamine 
increased expression of circadian clock molecule genes such  
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as Per1, Per2, Bmal1, and Npas2 in the brain [9-11]. Re-
cently, we detected the significant association between 
prokineticin 2 receptor gene (PROKR2), which is one of the 
clock genes, and Japanese methamphetamine dependence 
patients [12]. 
  Recently, rev-erb alpha and glycogen synthase kinase-3  
(GSK-3), which are known to be important circadian 
components [13], have been discussed in relation with 
lithium. Several studies have revealed that lithium affects 
circadian rhythms through GSK-3 [14-16]. Yin et al. 
showed that Rev-erb alpha is a target of GSK-3 kinase 
activity, needed to mediate this effect to regulate circadian 
rhythms [13]. These evidences indicate that rev-erb alpha 
gene (NR1D1) is a good candidate gene for the pathogenesis 
of methamphetamine dependence. 
  To evaluate the association between NR1D1 and meth-
amphetamine dependence, we conducted a case-control 
study of Japanese samples (215 methamphetamine depend-
ence and 232 controls) with three tagging SNPs selected by 
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2. MATERIALS AND METHODS 
2.1. Subjects 
  The subjects in the association analysis were 215 METH 
deprendence patients (175 males and 40 females; mean age ± 
standard deviation (SD) 36.3 ± 11.4 years) and 232 healthy 
controls (187 males and 45 females; 36.4 ± 11.3 years).   
The age and sex of the control subjects did not differ from 
those of the methamphetamine dependence patients. All   
subjects were unrelated to each other, ethnically Japanese, 
and lived in the central area of Japan. The patients were   
diagnosed according to DSM-IV criteria with consensus of at 
least two experienced psychiatrists on the basis of unstruc-
tured interviews and a review of medical records. One hun-
dred ninety-seven of the subjects with METH dependence 
had a diagnosis of co-morbid METH induced psychosis. 
METH-induced psychosis patients were divided into two 
categories of psychosis prognosis, the transient type and   
the prolonged type, which showed remission of psychotic 
symptoms within 1 month and after more than 1 month,   
respectively, after the discontinuance of methamphetamine 
consumption and beginning of treatment with neuroleptics; 
112 patients (56.9%) were the transient type, and 85 patients 
(42.1%) were the prolonged type. One hundred eighty-two 
subjects with METH-induced psychosis also had dependence 
on drugs other than METH. Cannabinoids were the most 
frequency abused drugs (21.4%), followed by cocaine 
(9.09%), LSD (9.09%), opioids (7.69%), and hypnotics 
(7.69%). Subjects with METH-induced psychosis were   
excluded if they had a clinical diagnosis of psychotic disor-
der, mood disorder, anxiety disorder or eating disorder. More 
detailed characterizations of these subjects have been   
published elsewhere [17, 18]. All healthy controls were also 
psychiatrically screened based on unstructured interviews. 
None had severe medical complications such as liver cirrho-
sis, renal failure, heart failure or other Axis-I disorders   
according to DSM-IV. 
  The study was described to subjects and written informed 
consent was obtained from each. This study was approved by 
the Ethics Committee at Fujita Health University, Nagoya 
University School of Medicine and and each participating 
member of the Institute of the Japanese Genetics Initiative 
for Drug Abuse (JGIDA). 
2.2. SNPs Selection and Linkage Disequilibrium (LD) 
Evaluation 
  We first consulted the HapMap database (release#20/ 
phase II, Jan 2006, www.hapmap.org, population: Japanese 
Tokyo, minor allele frequencies (MAFs) of more than 0.05) 
and included 5 SNPs covering NR1D1 (5’-flanking regions 
including about 750 bp from the initial exon and about 1 kb 
downstream (3’) from the last exon: HapMap database con-
tig number chr17: 35501880..35510616). Then three ‘tag-
ging (tag) SNPs’ were selected with the criteria of r
2 thresh-
old greater than 0.8 in ‘pair-wise tagging only’ mode using 
the ‘Tagger’ program (Paul de Bakker, http://www/broad. 
mit.edu/mpg/tagger), in Haploview [19], three ‘tag SNPs’ 
(rs939347, rs2071427 and rs3744805) were selected for the 
following association analysis. 
2.3. SNPs Genotyping 
  We used TaqMan assays (ABI: Applied Biosystems, Inc., 
Foster City, CA,) for all SNPs. One allelic probe was labeled 
with FAM dye and the other with the fluorescent VIC dye. 
The plates were heated for 2 min at 50°C and 95°C for 10 
min, followed by 45 cycles of 95°C for 15 s and 58°C for 1 
min. Please refer to ABI for the primer sequence. Detailed 
information is available on request. 
2.4. Statistical Analysis 
  Genotype deviation from the Hardy-Weinberg equilib-
rium (HWE) was evaluated by chi-square test (SAS/ 
Genetics, release 8.2, SAS Japan Inc, Tokyo, Japan). 
  Marker-trait association analysis was used to evaluate 
allele- and genotype-wise association with the chi-square test 
(SAS/Genetics, release 8.2, SAS Japan Inc, Tokyo, Japan), 
and haplotype-wise association analysis was conducted with 
a likelihood ratio test using the COCAPHASE2.402 program 
[20]. We used the permutation test option as provided in the 
haplotype-wise analysis to avoid spurious results and correct 
for multiple testing. Permutation test correction was per-
formed using 1000 iterations (random permutations). Power 
calculation was performed using a genetic power calculator 
[21]. The significance level for all statistical tests was 0.05.  
3. RESULTS 
  The LD structure of NR1D1 from the HapMap database 
samples can be seen our previous paper [22]. Genotype fre-
quencies of all SNPs were in HWE. We did not detect be-
tween all tagging SNPs and METH dependence in the Japa-
nese population in the allele /genotype-wise (Table 1 ) or 
haplotype-wise analysis (P  haplotype= 0.775). In addition, we 
found no association between four tagging SNPs and 
METH-induced psychosis patients in the allele /genotype-
wise (Table 1) or haplotype-wise analysis (P haplotype= 0.699). 
  In the power analysis, we obtained more than 80% power 
for the detection of association when we set the genotype 
relative risk at 1.63-1.86 in METH dependence for NR1D1 
under a multiplicative model of inheritance  
4. DISCUSSION 
  We did not find an association between NR1D1 and 
Japanese METH dependence and METH-induced psychosis 
patients. Therefore, we reasoned that NR1D1 may not play 
an important role in the pathophysiology of METH depend-
ence and METH-induced psychosis in the Japanese popula-
tion. However, because our samples are small, we considered 
that there is a possibility of statistical error in these results. 
  Recently, we reported that NR1D1 was not associated 
with major depressive disorder and selective serotonin reup-
take inhibitor response to major depressive disorder [7, 22]. 
On the other hand, we detected the associations between 
PROKR2 and not only mood disorders including major de-
pressive disorder and bipolar disorder but also METH de-
pendence and METH-induced psychosis in the Japanese 
population [12, 23]. We hypothesized that mood disorders 
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  A few points of caution should be mentioned with respect 
to our results. Firstly, the lack of association may be due to 
small sample size. Ideal samples for this study are METH 
use disorder samples with and without dependence and psy-
chosis. Because we had only a few METH use disorder sam-
ples without dependence and psychosis, and we wanted to 
avoid statistical error, we did not perform an association 
analysis with these samples. Secondly, we did not include a 
mutation scan to detect rare variants. We designed the study 
based on the common disease-common variants hypothesis 
[24]. Further investigation will be required, such as medical 
resequencing using larger samples. However, statistical 
power is needed to evaluate the association of rare variants. 
To overcome these limitations, a replication study using 
larger samples or samples of other populations will be re-
quired for conclusive results [25]. 
  In conclusion, our results suggest that NR1D1 may not 
play a role in the pathophysiology of METH dependence in 
the Japanese population. However, because we did not per-
form a mutation scan of NR1D1, a replication study using a 
larger sample may be required for conclusive results. 
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